A total of 2,247 venture capital (VC) funding deals were announced in China during January to July 2022 while the disclosed funding value of these deals stood at $32.7 billion, according to GlobalData, a leading data and analytics company.
An analysis of GlobalData’s Financial Deals Database reveals that China has witnessed a fluctuating VC funding activity month-on-month so far in 2022 with July reversing the growth witnessed during the previous month.
Aurojyoti Bose, Lead Analyst at GlobalData, comments: “VC funding deal volume declined marginally by 0.3% in July compared to the previous month while the corresponding deal value declined by a massive 29.2%.
“The major setback in deal value despite a marginal decline in VC funding deal volume in July is indicative of the growing risk aversion by investors in the wake of the ongoing geopolitical and macroeconomic headwinds. However, it is in line with the declining trend in VC funding activity across several key markets globally.”
Nevertheless, China witnessed the announcement of several $100 million+ VC funding deals so far in 2022. Some of these include the $785.7 million funding raised by Chongqing Changan, $671 million raised by CanSemi, $400 million capital raised by Hong Kong Asia Medical, $400 million raised by Jidu Auto, $300 million raised by Megarobo Technology, and $300 million capital raised by Newlink Group.
